AZ'5538

AZ'5538
Identifiers
	IUPAC name 2-chloro-4-ethoxy-5-(morpholin-4-yl)-N-[(5-[(4-methylpiperazin-1-yl)methyl]-1,3-benzothiazol-2-yl)carbamoyl]benzamide;
Chemical and physical data
Formula	C27H33ClN6O4S
Molar mass	573.11 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(Nc1sc2ccc(CN3CCN(C)CC3)cc2n1)NC(=O)c1cc(N2CCOCC2)c(OCC)cc1Cl;
	InChI InChI=InChI=1S/C27H33ClN6O4S/c1-3-38-23-16-20(28)19(15-22(23)34-10-12-37-13-11-34)25(35)30-26(36)31-27-29-21-14-18(4-5-24(21)39-27)17-33-8-6-32(2)7-9-33/h4-5,14-16H,3,6-13,17H2,1-2H3,(H2,29,30,31,35,36); Key:CHVMFPVXGKKDEC-UHFFFAOYSA-N;

FormulaC₂₇H₃₃ClN₆O₄S

Molar mass573.11 g·mol⁻¹

3D model (JSmol)

Interactive image

AZ'5538 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 1 (GPR81). It has been used to investigate the role of GPR81 in the regulation of blood lipid profile and blood pressure.^[1]^[2]

[1]

[2]

Identifiers

IUPAC name 2-chloro-4-ethoxy-5-(morpholin-4-yl)-N-[(5-[(4-methylpiperazin-1-yl)methyl]-1,3-benzothiazol-2-yl)carbamoyl]benzamide
Chemical and physical data
Formula	C₂₇H₃₃ClN₆O₄S
Molar mass	573.11 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(Nc1sc2ccc(CN3CCN(C)CC3)cc2n1)NC(=O)c1cc(N2CCOCC2)c(OCC)cc1Cl
InChI InChI=InChI=1S/C27H33ClN6O4S/c1-3-38-23-16-20(28)19(15-22(23)34-10-12-37-13-11-34)25(35)30-26(36)31-27-29-21-14-18(4-5-24(21)39-27)17-33-8-6-32(2)7-9-33/h4-5,14-16H,3,6-13,17H2,1-2H3,(H2,29,30,31,35,36) Key:CHVMFPVXGKKDEC-UHFFFAOYSA-N

Related Articles